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Abstract Anoctamin 6 (ANO6), also known as TMEM16F,
has been shown to be a calcium-activated anion channel with
delayed calcium activation. The cellular function of ANO6 is
under debate, and different groups have come to different
conclusions about ANO6’s physiological role. Although it is
now quite well established that ANO6 is distinct from the
volume-regulated anion channel, it is still unclear whether
ANO6 or other anoctamins can be activated by cell swelling.
In this study, we suggest that ANO1, ANO6, and ANO10 do
not contribute to the volume-activated current in ANO-
overexpressing HEK293 cells. Furthermore, knock-down of
ANO6 in Ehrlich ascites tumor cells (EATC) and Ehrlich–
Lettre ascites (ELA) did not decrease but instead significantly
increased swelling-activated membrane currents. Knock-
down of ANO6 in EATC did not reduce regulatory volume
decrease (RVD) in the absence of extracellular calcium,
whereas it significantly reduced RVD in the presence of
calcium. Interestingly, we found that knock-down of ANO6
in ELA cells resulted in a decrease in cisplatin-induced
caspase-3 activity, confirming earlier findings that ANO6 is
involved in apoptosis. Finally, knock-down of ANO1 and
ANO6 did not affect the volume-sensitive release of taurine
in ELA cells. Thus, our data provide evidence that ANO6
cannot be activated directly by cell swelling unless Ca2+ is
present. We also conclude that ANO6 carries a current during
RVD, provided extracellular calcium is present. Thus, swell-
ing activation of ANO6 requires the presence of free calcium.
Keywords ANO6 . TMEM16F . VRAC . Volume
regulation . Apoptosis
Introduction
Anoctamin 6 (ANO6), also known as TMEM16F, is a mem-
ber of the anoctamin family of transmembrane proteins, which
comprises ten members in vertebrates (ANO1–10). Three of
the members, ANO1, ANO2, and ANO6 have convincingly
been shown to be calcium-activated chloride channels
(CaCCs) [2, 9, 28, 31–33, 36], whereas the functions of the
remaining members are less well known. Several anoctamins
are known to be mutated or dysregulated in human diseases,
such as musculoskeletal disorders, ataxias, and several types
of cancer, which emphasizes the need to thoroughly study
them [4]. ANO6 is interesting because it has been shown that
mutations in this protein are the cause of the congenital
bleeding disorder Scott syndrome in humans [34]. ANO6’s
involvement in blood coagulation was confirmed in a study of
ANO6 knock-out mice, which showed prolonged bleeding
time compared with wild-type (WT) mice [37]. Another
knock-out mouse study suggested that ANO6 is also impor-
tant for embryonic development of skeletal tissues [6]. Finally,
changes in alternative splicing of human ANO6 are associated
with the development of metastasis in breast cancer [5].
ANO6 has been suggested to be involved in a diverse array
of processes in the cell, such as externalization of
phosphatidylserine [23, 34], cell volume regulation [1], and
cell migration [13]. Although it is now well established that
ANO6 constitutes a Ca2+- and depolarization-activated anion
channel [1, 24, 31, 33], Yang et al. found that it was a
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nonselective cation channel [37]. Our group recently conduct-
ed a thorough investigation of the properties of the ANO6
channel [9]. We found that ANO6 is a plasma membrane-
located Ca2+-activated anion channel with a relatively high
cation permeability that is correlated with the ANO6-
associated anion permeability (PNa=0.3 PCl). ANO6’s prop-
erties differed significantly from those of ANO1, including a
markedly higher EC50 for Ca
2+ and a delay of several minutes
from cytosolic (Ca2+) increase to Cl− current activation.
In a study from Almaca et al., it was suggested that some
anoctamins, including ANO6, contribute to the swelling-
activated chloride current (ICl, swell) [1]. Knock-down (KD)
of ANO6 significantly reduced ICl, swell and impaired the cell’s
ability to undergo regulatory volume decrease (RVD) in re-
sponse to osmotic cell swelling. Recently, however, the results
of Shimizu et al. showed that ANO6 is different from the
volume-regulated anion channel (VRAC) [33]. Furthermore,
Kunzelmann et al. excluded ANO6 as a VRAC candidate, as
ANO6 has none of the characteristic fingerprints of VRAC,
i.e., isovolumic activation by a decrease in intracellular ionic
strength or cell perfusion with GTPγS [17]. Finally, our
studies indicated a significant difference between the two
channels as revealed by their current responses to a step
voltage protocol. Following the initial ohmic current response
to a V-step into the positive region of membrane potentials,
ANO6 currents are slowly activated [9, 25] in contrast to
VRAC currents which are known to be slowly deactivated
[12, 24]. ANO6 is thus not identical with VRAC. However,
there are still ongoing discussions as to whether ANO6 is
activated by cell swelling and whether ANO6 contributes to
RVD. This is investigated in the present study. Additionally,
we looked at the relation between ANO6 and another still
unidentified anion channel, the volume-sensitive organic
osmolyte and anion channel (VSOAC), which has previously
been suggested to be identical to VRAC, although convincing
evidence now indicate that they are distinct channels [12].
Finally, we examined the possible role of ANO6 in cisplatin-
induced apoptosis, which is a process that is highly dependent
on cell shrinkage [29].
Materials and methods
Cell culture and transfection
Three different model cell lines were used: The mouse-
derived Ehrlich ascites tumor cells (EATC) and Ehrlich–
Lettre ascites (ELA) cells and the human-derived human
embryonic kidney 293 (HEK293) cells. All cells were main-
tained at 37 °C aerated with 5 % CO2:95 % O2. HEK293 cells
were maintained in DMEM and EATC and ELA cells were
kept in RPMI-1640. 10 % fetal bovine serum and 1 %
penicillin/streptomycin were added to each media. The
medium for the EATC and ELA KD clones and the EATC
overexpression clones was supplemented with 10 μg/mL
blasticidin to select for resistant clones. EATC and ELA cells
were transfected using Lipofectamine 2000 (Invitrogen,
Taastrup, Denmark) and HEK293 cells using Trans-IT®-293
(Mirus Bio LLC, Madison, WI, USA). HEK293 cells were
used for electrophysiological recordings 24–48 h after
transfection.
Isolation of RNA, reverse transcription, PCR, and cDNA
cloning
Total RNA was isolated from EATC using the RNeasy Mini
Kit (Qiagen, Ballerup, Denmark). cDNA was prepared in a
total volume of 40 μL by hybridization of 500 ng oligo dT
primers to 4μg RNA at 65 °C for 5 min followed by extension
at 42 °C for 50 min in the presence of 200 U Superscript II
reverse transcriptase (Invitrogen, Brondby, Denmark),
500 μM dNTP, 10 μM DTT, 50 mM Tris–HCl, 75 mM
KCl, and 3 mM MgCl2, pH 8.3. Finally, the RT was
inactivated at 70 °C for 15 min. PCR was performed in a total
volume of 20 μL containing 1 μL of the RT reaction, 0.5 mM
dNTPs, 0.5 μM of each primer, 2 mM MgCl2 and 2 U Taq
polymerase in PCR buffer (conventional PCR) or 2 U Pfu
Ultra II fusion HS polymerase (Stratagene, Santa Clara, CA,
USA) in Pfu PCR buffer (for cloning). PCR consisted of a
denaturizing step of 2 min at 95 °C followed by 35 cycles of
95 °C in 30 s, 58 °C in 30 s and 72 °C in 2 min. Primers used
for PCR were: Ano1_for; 5′-gacctgggctat gaggttca-3′,
Ano1_rev; 5′-ggctgatgtctttggggata-3′, Ano6_for; 5′-
gcagcccttggatcttatca-3′, Ano6_rev; 5′-tgctgtagctcaacggtg tc-
3′, Ano10_for; 5′-tctgagtggaccagccttct-3′, Ano10_rev; 5′-
agaagagtgaggcgaagcaa-3′. Primers used to clone and generate
attB-flanked gateway compatible PCR products were
Ano6_for; 5′-ggggacaagtttgtacaaaaaagcaggcttcaccatgcagatg
atgactaggaaggtc-3′, Ano6_rev; 5′-ggggaccactttgtacaag
aaagctgggtctcattcgagttttggccgcacg-3′, Ano1_for; 5′-
ggggacaagtttgtacaaaaaagcaggcttcaccatgagggtccccgagaagtac-
3′, Ano1_rev; 5′-ggggaccactttgtacaagaaagctgggtcctacagcgcgt
ccccatggga-3′, Ano10_for; 5 ′-ggggacaagtttgtacaaaa
aagcaggcttcaccatgagagtgactttatcaacgctg-3′, Ano10_rev; 5′-
ggggaccactttgtacaagaaagctgggtctcaggtagcttccttcccatct-3′.
PCR products were excised from 0.8% agarose gels and DNA
extracted using E.Z.N.A gel extraction kit (Omega Bio-tek,
Norcross, GA, USA). PCR products of mAno6, mAno1 or
mAno10 were then recombined into pDONR221 using BP
Clonase according to the manufacturer’s instructions
(Invitrogen, Taastrup, Denmark) to generate mAno6, mAno1
or mAno10 entry clones. After transformation into E. coli and
selection using 50 μg/mL kanamycin, DNAwas purified and
inserts in entry clones confirmed by full-length DNA sequenc-
ing. Finally, using LR-clonase mix, the inserts from entry
clones were recombined into pcDNA6.2/EmGFP-Bsd/V5-
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DEST and pcDNA3.1-DEST47 to generate vectors co-
expressing mANO6, mANO1 or mANO10 and EmGFP.
Expression plasmids were produced in E. coli using ampicillin
(100 μg/mL) as selection agent.
To determine the mAno6 mRNA level in EATC (WT and
KD), real-time qPCR was performed in triplicates (EATC)
using a Stratagene MX4000 Real-Time PCR system and
SYBRGreen PCR Master Mix (ABI) in a total volume of
20 μL containing 1 μL of the RT reaction, 200 nM of primers
and 10 μL 2× mastermix. Primers used for qPCR were:
Ano6_for; 5′-gcagcccttggatcttatca-3′, Ano6_rev; 5′-
tgctgtagctcaacggtg tc-3′, Arp_for; 5′-cgacctggaagtccaactac-
3′, Arp-rev; and 5′-atctgcatctgcttg-3′. Target expression level
was normalized to the reference gene level (mArp) and the
relative expression ratio calculated using the equation:
Eratio ¼ Etarget
ΔC tð Þtarget controltreatedð Þ
ErefΔC tð Þref controltreatedð Þ
where Etarget and Eref are the PCR amplification efficiencies
for the target gene and reference gene, respectively, and
ΔC(t)target and ΔC(t)ref the change in C(t) values for target
and reference gene. ANO6 and ANO1 mRNA and protein
levels in WT and KD ELA cells were previously determined
by Jacobsen et al. [13].
Gel electrophoresis and Western blotting
Cells were lysed in 95 °C lysis buffer (150 mMNaCl, 20 mM
HEPES, 1 mM EDTA, 10 % Glycerol, 0.5 % Triton X-100,
and 0.5 % SDS) with protease inhibitors (Roche Applied
Science) and phosphatase inhibitors added. The lysates were
subsequently homogenized, and the supernatant was collected
by centrifugation. Protein concentrations were determined
using Bio-Rad DC protein assay. SDS-polyacrylamide gel
electrophoresis were performed using a 10 % gel
(Invitrogen) and transferred to nitrocellulose membranes.
The membranes were dyed with Ponceau Red (Sigma) and
washed in TBST (10 mM Tris·HCl, pH 7.5, 120 mM NaCl,
and 0.1 % Tween 20) before being blocked in a 5% nonfat dry
milk and TBST solution. Membranes were incubated with
primary antibody at following concentrations: 1:50 ANO6
(gift from Prof. Kunzelmann), 1:8000 Alpha-tubulin.
Membranes were washed in TBST before introduction to
secondary antibody (Sigma) 1:5000. The protein bands were
visualized using 5-bromo-4-chloro-3-indolyl phosphate-nitro
blue tetrazolium (BCIP/NBT; Kirkegaard and Perry Lab) and
scanned or alternatively visualized using using enhanced
chemiluminiscence using horseradish peroxidase and luminol.
Construction of microRNA plasmids
Interfering microRNA (miRNAi) KD of mANO6 and
mANO1 was achieved using BLOCK-iT™ Pol II miR
RNAi Expression technology (Invitrogen, Taastrup,
Denmark). miRNAi targeting mAno6 and mAno1 were de-
signed using Invitrogen’s online design tool generating sense
and antisense single-stranded DNA strings (ssDNA). DNA
sequences were: ANO6, sense, 5′-tgctgtttagcgggagtttgatgtgc
gttttggccactgactgacgcacatcactcccgctaaa-3′, antisense, 5′-
cctgtttagcgggagtgatgtgcgtcagtcagtggccaaaacgcacatcaaactccc-
gctaaac-3′; ANO1, sense, 5′-gacctgggctat gaggttca-3′ and an-
tisense 5′-ggctgatgtctttggggata-3′. The two ssDNAs were
annealed in annealing buffer generating a dsDNA, which
was then ligated into pcDNA™6.2-GW/EmGFP-miR gener-
ating miR-ANO6-KD or miR-ANO1-KD plasmids. Plasmids
were transformed into omnimax T-1 E. coli (Invitrogen,
Taastrup, Denmark) and selected using spectinomycin as an-
tibiotic (50 μg/μL). Plasmid inserts were confirmed by
sequencing.
Generation of mANO6 or mANO1 stable KD in EATC
and ELA
EATC and ELA cells were transfected with miR-ANO6-KD
or miR-ANO1-KD plasmids using Lipofectamine 2000
(Invitrogen, Taastrup, Denmark), incubated for 4 h and then
re-suspended in fresh medium containing 10 μg/mL
blasticidin. After 1 week selection, single cells were picked
and transferred to 24- or 96-well trays and allowed to grow
into a full clone in the presence of blasticidin. Clones were
analyzed using qPCR (as described above) and, if possible,
using Western blot analysis [13]. The selected EATC KD
clone was named miR-ANO6-1 (EATC ANO6-KD) and the
selected ELA KD clones were named miR-ANO6-10 (ELA
ANO6-KD), miR-ANO6-15 and miR-ANO1-7 (ELA
ANO1-KD).
Electrophysiological recordings
Cells were plated on poly-L-lysine-coated cover slips. In ex-
periments with overexpression of ANO proteins, transfected
cells were identified by their EmGFP expression using a
fluorescence microscope. Whole-cell voltage-clamp record-
ings were performed with the Axopatch 200B amplifier
interfaced to a Digidata 1440A using pClamp10 for recording
and analysis (Molecular Devices). Analog signals were ac-
quired at 2.5 kHz and filtered at 1 kHz. All recordings were
performed at room temperature (20 °C). Patch pipettes were
fabricated from borosilicate glass capillaries using a DMZ-
Universal Puller (Zeitz Instruments,Munich, Germany) with a
resistance of 2–5 MΩ when filled with the internal solution.
For activation of ICl, swell, the pipette solution contained (in
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mM): CsCl, 90; MgCl2, 2; EGTA, 10; HEPES, 10; Na2-ATP,
5, pH 7.2 with TRIS or NaOH and osmolality adjusted to 295
mOsmol/kg with D-mannitol. The bath was a modified
Ringer’s solution and, in the EATC andHEK293 experiments,
it contained (in mM): NaCl, 90; CaCl2, 1; MgCl2, 1; and
HEPES, 10, at pH 7.4 with TRIS and osmolality adjusted to
190 mOsmol/kg (hypotonic) or 300 mOsmol/kg (isotonic)
with D-mannitol. For ELA experiments, the bath contained
(in mM): NaCl, 150; CaCl2, 1.5; MgCl2, 1; HEPES, 10;
glucose, 10, pH 7.4 with NaOH and osmolality adjusted to
317 mOsmol/kg (isotonic) with D-mannitol. To produce the
hypotonic bath, the isotonic solution was diluted 30 % (final
osmolality: 222 mOsmol/kg). Osmolality was measured using
a vapor pressure depression osmometer (Wescor Vapro 5520).
Series resistance was compensated by 60–70 %.
Liquid junction potential changes due to extracellular Cl−
replacement were calculated with the Clampex10 software
(Axon Instruments) and corrected for by Vm=Vtest−3.8 mV
(EATC and HEK293 experiments) orVm=Vtest−4.2 mV (ELA
experiments) for ICl, swell. A ramp protocol ranging from Vtest=
−100 to +100 mV (EATC experiments) or Vtest=−80 to +
80 mV (ELA experiments) over 1 s with a holding potential
of Vtest=0 mV was run continuously with 15 s intervals to
follow the current activation. A step protocol with a holding
potential, Vhold=0 mVand steps of 1 s duration ranging from
Vtest=−100 to +100 mV with 20 mV increments was applied
before and after hypotonic stimulation of ICl, swell.
Cell volume measurements
Cell volume was measured by electronic cell sizing in a
Beckman–Coulter Multisizer™ 3 (Beckman–Coulter,
Copenhagen, Denmark). The tube orifice was 100 μm. Cell
density was 20,000 cells/mL, equivalent to a cytocrit of
0.002 %. Mean cell volume was calculated as the median of
the volume distribution curves after calibration with latex
beads (nominal diameter 10 μm). Volume measurements
were carried out in 37 °C isotonic Ringer’s solution (274
mOsmol/kg) for initial cell sizing of the control volume,
and in 37 °C hypotonic Ringer’s solution (160 mOsmol/kg)
for the RVD responses. Media used for cell volume mea-
surements were filtered (Millipore filters, 0.45 mm) prior to
experiments. Both Ringer’s solutions contained (in mM):
Na+, 75; Cl−, 75; K+, 2.5; Mg2+, 0.5; Ca2+, 0.5; SO4
2−, 0.5;
HPO4
2–, 0.5; MOPS, 3.3; TES, 3.3; HEPES, 5. The osmo-
lality of the isotonic solution was adjusted using sucrose.
For Ca2+-free experiments, CaCl2 was substituted by NaCl
and EGTAwas added to a concentration of 1 mM.
Taurine efflux measurements
ELAWT and KD cells were grown in 6-well plates to 80 %
confluency. Before the start of the experiment, the cells were
loaded with 3H-taurine (final concentration: 0.04 μM) and
incubated for 2 h at 37 °C and 5 % CO2. After incubation,
the cells were washed with an isotonic (300 mOsmol/kg)
NaCl solution containing (in mM): NaCl, 143; KCl, 5;
Na2HPO4, 1; CaCl2, 1; MgSO4, 1; HEPES, 10, and pH
adjusted to 7.4. Avolume of 1 mL of isotonic NaCl was added
to each well at time zero, and every 2 min the solution in
each well was transferred to a vial and replaced by either
1 mL fresh isotonic solution (0–8 min) or fresh hypotonic
(200 mOsmol/kg) solution (10–24/30 min). The hypotonic
solution was obtained by dilution of the isotonic solution
with buffered water. Following the final removal of hypo-
tonic solution, 1 mL of 1 M NaOH was added to each well
to lyse the cells. The six-well plate was placed on a shaking
table for a minimum of 1 h. The cell lysates were then
transferred to vials; 1 mL ddH2O was added to each well
and subsequently transferred to a vial (this was repeated
twice); 3.5 mL Ultima Gold™ scintillation cocktail
(PerkinElmer) was added to each vial and the vial was shaken
thoroughly. 3H activity was measured using a beta-
scintillation counter (Packard). Assuming that there is only
one channel type facilitating the taurine release, and that
taurine release follows a mono-exponential time course, the
fractional rate constant (k) for taurine release in each time
interval can be deduced from the following equation:
At=At–Δt*e
−k*Δt, where At is the cellular activity of
3H-labeled
taurine at the end of the given time interval (counts per
minute), At–Δt is the activity at the beginning of the interval
(counts per min), k is the fractional rate constant (minutes),
andΔt is the length of the interval (2 min). Rate constants for
taurine release under isotonic conditions were estimated as the
average of release rates at t=8 min and t=10 min, whereas the
values for hypotonic conditions were estimated as the maxi-
mal transport rate after shift to hypotonic bath solution.
Caspase-3 activity assay
Caspase-3 activity was measured using the Fluorometric
Homogenous Caspases Assay (Roche Applied Science).
10,000 ELAWT or KD cells per well were added to two 96-
well plates. The two 96-well plates were identical and used for
caspase-3 activity measurements and protein determination,
respectively. The plates were incubated at 37 °C and 5 % CO2
for 24 h. The medium was then replaced by medium contain-
ing 10μMcisplatin and the plates were incubated at 37 °C and
5 % CO2 for 24 h. In the plate used for protein determination,
the cells were washed in PBS, and lysis buffer (10 mM Tris-
Cl, 1 % SDS) was added. This plate was then incubated at -
80 °C for 24 h and protein concentrations were determined
using a colorimetric DC protein assay (Bio-Rad), a FLUOstar
Optima plate reader (BMG Labtech), and a standard curve
based on samples with known protein concentrations. The
plate used for caspase-3 activity measurements was frozen
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(30 min at −80 °C) and thawed (45 min at RT) three times to
promote cell lysis. DEVD-R110 and incubation buffer from
the assay kit was added to the cells and the plate was covered
in aluminum foil and incubated at 37 °C for 1 h. Fluorescence
was then measured at 520 nm with an excitation wavelength
of 485 nm using the FLUOstar Optima plate reader. The
caspase-3 activity of each cell line was calculated as the mean
of the measurements in either three or five wells and fluores-
cence from wells containing only growth medium, DEVD-
R110 and incubation buffer was subtracted from the measure-
ments to remove background fluorescence. The caspase-3
activities were then normalized to the measured protein con-
centrations. Finally, all results were normalized to the caspase-
3 activity of WT cells that had not been exposed to cisplatin.
Statistics
ANO-KD or ANO-expressing cells were compared with WT
or mock-transfected cells using two-sided Student’s t tests
assuming either equal or unequal variances depending on the
result of an F test. The results were considered significant
when p<0.05.
Results
ICl, swell in mANO1, mANO6, or mANO10-transfected
HEK293 cells and mANO6-transfected EATC
To investigate whether anoctamins generate volume-
sensitive anion currents, we measured the swelling-
activated whole cell Cl− current (ICl, swell) under strongly
Ca2+-buffered conditions (at a nominal (Ca2+)p of zero and
10 mM EGTA in the pipette solution, i.e., no contribution
from CaCC). Under these conditions, perfusion with a 36 %
hypotonic solution resulted in visible cell swelling and
development of an outwardly rectifying current (Fig. 1a).
This membrane current showed all the classical features
typical of VRAC as described for many cell types [12,
25], e.g., time-dependent inactivation following voltage-
clamp steps to high positive potentials (Fig. 1a, right).
The deactivation at positive potentials is in contrast to what
has been found for the ANO6 channel (compare with [9],
Figs. 3 and 4). The swelling-activated currents were record-
ed in mock-, mANO1-, mANO6-, and mANO10-
expressing HEK293 cells, which were visually identified
by their EmGFP expression. Figure 1b–d shows the average
time courses of the current development toward steady state
following hypotonic treatments. Although we expected to
see an increase in current if ANO6 contributed to the
swelling-activated current, no significant changes in the
current was found in either mANO1-, mANO6-, or
mANO10-expressing cells when compared with mock-
transfected cells (Fig. 1e). If anything, there was a slight
tendency that ANO1 and ANO10 overexpression induced a
suppression of the endogenous volume-activated current
(Fig. 1c–e). It should be noted that the present patch clamp
experiments were performed at room temperature, but even
though ANO1 is shown to be temperature dependent in
nociceptive neurons [3], the contribution of both ANO1
and ANO6 to the total Ca2+-activated current is still prom-
inent in the transfected HEK cells at room temperature [9].
The reversal potentials measured at 180 s of hypotonic
stimulation were also unchanged. Expression of mANO6
in EATC cells did not significantly change the volume-
activated current compared with WT either (maximal
VRAC current at −75 mV: WT, −23.1±4.7 pA/pF (n=16);
mANO6 overexpression, −20.6 ± 4.0 pA/pF (n=6),
p=0.76). Thus, overexpression of neither of the studied
anoctamins enhanced the volume-sensitive currents of
HEK293 cells or EATC under conditions of zero intracellular
calcium.
ICl, swell in EATC and ELA cells with stable KD of ANO6
To further investigate the relationship between ANO6 and
the swelling-induced anion current, we compared whole
cell currents under hypotonic and Ca2+-free conditions in
WT and two different ANO6 KD clones, in EATC and ELA
cells, respectively. KD in EATC (KD clone: miR-ANO6-1)
was confirmed using qPCR, which showed a significant
45±11 % reduction (p=0.009; n=6) in the ANO6 mRNA
level compared with WT, and Western blotting (Fig. 2d).
KD in ELA cells (KD clone: miR-ANO6-10) on both
mRNA and protein levels was previously shown by
Jacobsen et al. (see [13], Fig. 1a). KD of ANO6 in ELA
cells was not compensated by a concomitant upregulation
of ANO1 and ANO10 [13]. From Fig. 2a, b, it is seen that
the current was activated shortly after application of hypo-
tonic extracellular solution and had the properties charac-
teristic of VRAC. If ANO6 contributed to the swelling-
activated current, we would expect the ANO6-KD to de-
crease the current. Instead, we found that ANO6-KD in
both EATC (Fig. 2c, e) and ELA cells (Fig. 2f) resulted in
a significant increase in VRAC activation. This surprising
result may indicate interaction between the expression
levels of the two anion channels, the mechanism of which
is unknown. What is of importance for our argumentation,
however, is that the volume-activated currents are not de-
creased in ANO6-KD cells.
RVD in WT and ANO6-KD EATC
To explore if ANO6, like VRAC, has a Ca2+-independent role
in cell volume regulation, we measured RVD, i.e., the
swelling-induced cell volume recovery, in WT and ANO6-
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Fig. 1 VRAC currents in mANO1, mANO6, and mANO10 transfected
HEK293 cells. Measurements were conducted with no intracellular Ca2+
and 10 mM EGTA. a Representative current development (left) and
current–voltage dependency (right) of the endogenous VRAC current in
a mock-transfected HEK293 cell exposed to hypotonic superfusate. b
VRAC current development in mANO6 (n=5), cmANO1 (n=9), and d
mANO10 (n=11) transfected HEK293 cells; each compared with mock
(n=8). e The average IV-relations at maximal current for mock and
mANO6-, mANO1-, and mANO10-transfected cells, generated from
ramp protocol sweeps (from −104 to +96 mV). Data in (b–e) are repre-
sented as mean±SE and in (e), WT was compared with the ANO-
transfected cells at ±15, ±30, ±45, ±60, and ±75 mV using two-sided
Student’s t tests and no significant differences were found
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Fig. 2 VRAC currents in WT and ANO6-KD EATC and ELA cells.
Measurements were conducted with no intracellular Ca2+ and 10 mM
EGTA. a Representative current development (left) and current–voltage
dependency (right) of the endogenous VRAC current in a WT EATC
exposed to hypotonic solution. b As in (a) with an ANO6-KD cell. c
VRAC current development inWT (n=15) and ANO6-KD (n=23) EATC
exposed to hypotonic solution. d Western blot demonstrating KD of
ANO6 in EATC. Blot is typical of three separate experiments. e WT
and ANO6-KD EATC: the average IV relation at maximal current gen-
erated from ramp protocol sweeps (from −104 to +96 mV). f WT and
ANO6-KD ELA cells: the average IV relation at maximal current gener-
ated from ramp protocol sweeps (from −84 to +76 mV). Values in (c), (e),
and (f) represent mean±SE and in (e) and (f), WTwas tested against KD at
±15, ±30, ±45, ±60, and ±75 mV using two-sided Student’s t tests (e;
**p<0.01 at all points; f; *p<0.05; **p<0.01)
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KD EATC with extracellular Ca2+ replaced by 1 mM EGTA.
Under such conditions, plasma membrane Ca2+ influx is
eliminated without affecting Ca2+ release from intracellular
stores. As the volume-sensitive K+ and Cl− fluxes, and hence
RVD, are temperature dependent [30], we performed the
Coulter counter experiments at 37 °C to evaluate the effect
of ANO6-KD under more physiological conditions. KD of
ANO6 (KD clone: miR-ANO6-1) was confirmed as described
Fig. 3 Cell volume regulation in WT and ANO6-KD EATC. a Cell
volume measured by electronic cell sizing (Coulter Counter) over a 5-
min period following exposure to a 42 % hypotonic medium containing
no Ca2+ and 1 mM EGTA. Values are given relative to the initial cell
volume of each cell line and represent mean±SE of seven experiments. b
Cell volume measured as in (a) with EGTA in the medium replaced by
0.5 mMCa2+. Values represent mean±SE of 8 and 14 experiments inWT
and ANO6-KD EATC, respectively. c The absolute value of the initial
slope of the volume recovery from the time of maximal volume to 1 min
after is based on the values in (a) and (b). Values are presented as mean±
SE. Using two-sided Student’s t tests, WTand ANO6-KDwere compared
with each other (0 mM Ca2+o+EGTA, p=0.30; 0.5 mM Ca
2+
o, p=0.012)
and WT without Ca2+ was compared with WT with Ca2+ (p=0.005). d
The 3-min volume recovery was determined from maximal volume
towards the original volume after 3 min of hypotonic exposure, based
on the values in (a) and (b). Values are represented as mean±SE, and,
using two-sided Student’s t tests,WTandANO6-KDwere comparedwith
each other (0 mM Ca2+o+EGTA, p=0.76; 0.5 mM Ca
2+
o, p=0.002) and
WTwithout Ca2+ was compared withWTwith Ca2+ (p=0.015). *p<0.05;
**p<0.01
Fig. 4 Taurine efflux inWTand ANO1- and -6-KD ELA cells. aTaurine
efflux in WT (n=24) and ANO6-KD (n=7) ELA cells was measured for
30 min using the radiotracer technique and the efflux rate constants were
estimated in each 2-min time interval. After 10 min in isotonic solution,
the cells were exposed to a 33% hypotonic solution. bTaurine efflux was
measured as in (a) in WT (n=24), ANO6-KD (n=7), and ANO1-KD
(n=9) ELA cells. The isotonic rate constant was estimated as the average
of rate constants at t=8 min and t=10 min, whereas the hypotonic rate
constant was estimated as the maximal rate constant after hypotonic
exposure. Data in (a) and (b) are represented as mean±SE and in (b),
WT was compared with ANO-KDs using a two-sided Student’s t test
(ANO6-KD, p=0.038 (isotonic); p=0.39 (hypotonic); ANO1-KD,
p=0.000 (isotonic); p=0.69 (hypotonic)). *p<0.05; **p<0.01
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above. As seen in Fig. 3a, exposure of WT EATC to a 42 %
hypotonic shock induces rapid cell swelling which is followed
by the classic RVD response as described previously [12]. The
extent of the RVD response was calculated in two ways: as the
absolute value of the initial slope of volume recovery from the
time of maximal volume to 1 min after (Fig. 3c) and as the
recovery from maximal cell volume toward the original vol-
ume after 3 min of hypotonic exposure (Fig. 3d). The initial
slope in the WT cells was 0.092±0.007 min−1 (n=7) and was
not significantly different from the slope in ANO6-KD cells,
which was 0.079±0.009 min−1 (n=7; p=0.30) (Fig. 3c).
Similarly, the recovery after 3 min in the WT and ANO6-
KD cells was 85±7 % (n=7) and 82±8 % (n=7), respectively,
and no significant difference was seen between the two
(p=0.76) (Fig. 3d). Thus, these data show that ANO6, unlike
VRAC, is not able to contribute to RVD in the absence of
extracellular Ca2+. From Figs. 2e and 3a, it is seen that VRAC
activity in EATC is higher in ANO6-KD compared with
WT cells, whereas both cell lines show similar RVD effi-
ciency. This conforms with the previous demonstration that
the K+ conductance is rate limiting in the RVD response in
EATC, which prevents an increase in the Cl− conductance
to be seen [12].
We then tested if ANO6, through its role as a CaCC,
could contribute to RVD when extracellular Ca2+ was pres-
ent. In this experiment, the ANO6-KD cells showed a
significantly lower initial slope of 0.093±0.01 min−1
(n=14) when compared with 0.14±0.01 min−1 (n=8) in
the WT cells (p=0.012) (Fig. 3c). The recovery after
3 min in the ANO6-KD cells, 75.3±6.5 % (n=14), was also
significantly lower compared with WT, 109.2±5.2 % (n=8;
p=0.002) (Fig. 3d). When looking at WT cells, the data
show that removal of extracellular Ca2+ significantly re-
duces both the initial slope (p=0.005) (Fig. 3c) and the
recovery after 3 min (p=0.015) (Fig. 3d), whereas removal
of extracellular Ca2+ from ANO6-KD cells had no
significant effect on neither the initial slope (p=0.43) nor
the recovery after 3 min (p=0.56). These results suggest
that Ca2+ plays an important role in RVD in EATC, and that
this is, at least partly, due to the Ca2+-dependent activity of
ANO6. This seems to contradict previous results from our
group which showed that RVD in EATC does not depend
on Ca2+ [14]. However, the EATC investigated in our
previous study was cultured in the abdominal cavity of
female Naval Medical Research Institute mice, whereas
EATC in the present study were cultured in RPMI-1640
medium. The most likely explanation is that the in vivo-
generated cell line had a lower level of anoctamin expres-
sion. However, as this cell line is no longer available, a
direct proof of this notion cannot be carried out.
Taurine efflux in WT and ANO1- and ANO16-KD ELA cells
Efflux of organic osmolytes, such as taurine, plays an impor-
tant role in RVD [12, 20]. Despite this, the molecular identity
of the VSOAC, which facilitates this efflux, is not known.
Here, we investigate whether ANO1 and ANO6 could con-
tribute to the volume-sensitive release of taurine. Taurine
efflux in WT and ANO-KD ELA cells was measured using
the radiotracer efflux technique during isotonic and hypotonic
conditions. KD of ANO6 and ANO1 was confirmed by
Jacobsen et al. [13]. In bothWTand ANO-KD cells, exposure
to hypotonic solution resulted in a fast increase in the taurine
efflux rate constants followed by a slow decrease (Fig. 4a). In
contrast to what would be expected if anoctamins contributed
to taurine efflux, the taurine efflux rate constants in ANO1-
and ANO16-KD cells were similar to or higher than those of
WT cells (Fig. 4b). The ANO6-KD clone had a significantly
higher efflux than WT cells at isotonic conditions (p=0.038),
while there was no significant difference at hypotonic condi-
tions (p=0.39). In the ANO1-KD clone, taurine release at
isotonic conditions was significantly higher than in WT cells
(p=<0.001), but not significantly higher under hypotonic
conditions. The results of this functional test indicate that
neither ANO1 nor ANO6 are VSOAC.
Cisplatin-induced caspase-3 activity in WT and ANO6-KD
ELA cells
Apoptotic volume decrease (AVD) is an essential early step in
the apoptotic process [15, 22] and several ion channels involved
in RVD are also involved in AVD [1, 21, 26]. As ANO6, in the
presence of extracellular Ca2+, is involved in RVD, we inves-
tigated if KD of ANO6 affected the cells’ ability to undergo
apoptosis. Using a fluorometric assay, we measured the
caspase-3 activity in WT and ANO6-KD ELA cells, which
either had or had not been exposed to the apoptosis-inducing
drug cisplatin for 24 h (Fig. 5; results from KD clone miR-
ANO6-10 are shown; values are relative to the caspase-3
Fig. 5 Caspase-3 activity in WT and ANO6-KD ELA cells. Caspase-3
activity in WT (n=11) and ANO6-KD (n=11) ELA cells was measured
after 24 h exposure to medium containing either no or 10 μM cisplatin
using a fluorometric assay, and values were then normalized to the
caspase-3 activity of WT cells without cisplatin. Data are represented as
mean±SE and WT was compared with ANO6-KD using a two-sided
Student’s t test (p=0.41 (without cisplatin), p=0.028 (10 μM cisplatin)).
*p<0.05
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activity ofWTcells not exposed to cisplatin). Without cisplatin,
no significant difference was seen between WT and KD cells
(WT, 1.0 (n=11); miR-ANO6-10, 1.14±0.17 (n=11; p=0.41);
and miR-ANO6-15, 0.74±0.21 (n=4; p=0.30)). However, fol-
lowing cisplatin exposure, ANO6-KD cells showed significant-
ly less caspase-3 activity compared with WT cells (WT, 4.70±
1.1 (n=11); miR-ANO6-10, 1.76±0.34 (n=11; p=0.028); and
miR-ANO6-15, 1.08±0.07 (n=4; p=0.0092)). These results
suggest that ANO6 is involved in cisplatin-induced apoptosis.
Discussion
ANO6 and the volume-activated anion current
It has previously been suggested that ANO6 is activated
following cell swelling [1], and it could therefore be speculat-
ed that ANO6’s activity is volume regulated. In the present
study, however, expression of mANO1, mANO6, or
mANO10 in HEK293 cells and mANO6 in EATC, did not
affect swelling-activated currents in the absence of intracellu-
lar Ca2+ (10 mM EGTA added to the pipette solution)
(Fig. 1e). Moreover, KD of ANO6 in EATC and in ELA cells
did not reduce the swelling-induced current (Fig. 2e, f). These
results are showing that ANO6 as well as ANO1 and ANO10
do not contribute to cell volume-activated currents, which is in
agreement with the results obtained by Shimizu et al. [31].
This is not in conflict with the study by Almaca et al. who
found that expression of ANO1 and ANO2 enhanced ICl, swell
in whole-cell patch clamp experiments with 0.1 μM-free Ca2+
in the pipette, and knock-down of ANO1, ANO6, ANO8, and
ANO9 reduced ICl, swell under the same conditions [1]. They
hypothesized that the anoctamin-mediated ICl, swell was stim-
ulated through an autocrine mechanism that involves
swelling-induced ATP release, binding to the purinergic
P2Y2 receptors with a subsequent increase in intracellular
Ca2+. It follows that anoctamins’ role in ICl, swell and RVD
would be secondary to an increased intracellular (Ca2+).
ANO6 is involved in RVD in a Ca2+-dependent manner
EATC are well suited for the study of the putative role of
anoctamin channels in RVD. It is the first cell type in which
an increased Cl− permeability following hypotonic cell swell-
ing was demonstrated [10], and the cell swelling-activated
current as well as Ca2+-activated current are biophysically
and pharmacologically well characterized in these cells [27].
In a variety of cells, VRAC as well as CaCC are known to be
associated with the RVD response [12]. However, VRAC in
ELA cells does not require Ca2+ for activation [16] (see also
Figs. 1 and 2), whereas CaCCs are dependent on influx of
Ca2+. To approach the question of whether ANO6 is swelling-
activated per se, we investigated if ANO6 has a Ca2+-
independent role in RVD by studying cell volume recovery
in WT and ANO6-KD EATC in the absence of extracellular
Ca2+. Our results show that there is no significant difference
between WT and ANO6-KD cells in their ability to undergo
RVD in Ca2+-free solution. Almaca et al. previously showed
that ANO1, ANO6, ANO8, and ANO9 are essential for RVD
in HEK293 cells and that ICl, swell is reduced in the colonic
epithelium and in salivary acinar cells from mice lacking
expression of ANO1 [1, 18]. However, these experiments were
conducted in the presence of extracellular Ca2+. Thus, neither
their results nor their hypothesis mentioned above contradict
our conclusion. To replicate their results with our protocol, we
repeated our experiment in the presence of extracellular Ca2+.
We observed that ANO6-KD cells display the RVD response,
but it proceeds at a significantly slower rate compared with the
response inWTcells (Fig. 3c, d). This result shows that ANO6
contributes to the physiological RVD in EATC, but only in the
presence of Ca2+, i.e., under normal physiological conditions.
In whole cell patch clamp studies, the high intracellular Ca2+
required for ANO6 activation is secured by the free Ca2+
concentration in the pipette, whereas in the RVD response
of intact cells, the high intracellular Ca2+ at the
submembrane domains governing ANO6 activation de-
pends on a putative Ca2+ influx during RVD. Apparently,
in our experiments, this influx was sufficient for driving
Ca2+ above the threshold for activation of ANO6. The
effect of cell swelling on Ca2+i differs widely between cell
types, as does the dependence of RVD on extracellular
Ca2+. This is summarized and discussed in [12]. The Ca2+
dependence of RVD is likely to reflect the involvement of
Ca2+-activated K+ and/or Cl− channels.
ANO6 and ANO1 do not contribute to taurine efflux
Taurine is an essential organic osmolyte in most mammalian
cells, and taurine release after cell swelling is an important
component of the RVD response [12, 20]. Under isotonic
conditions, taurine release is low and the mechanism behind
it is unknown [20]. After hypotonic exposure, the VSOAC is
activated, allowing taurine efflux to drastically increase [11,
12]. VSOAC has not been identified at the molecular level and
was previously considered to be the same as VRAC.
However, evidence now indicates that they are distinct chan-
nels [19]. As anoctamins are involved in RVD, we speculated
if they were taurine channels. We therefore investigated the
effects of ANO1- and ANO6-KD on taurine efflux under
isotonic and hypotonic conditions. Our results clearly show
that swelling-induced taurine release is not reduced by ANO-
KD, i.e., ANO1 and ANO6 are different from VSOAC
(Fig. 4b). In some KD clones, we observed a small but
significant increase in taurine efflux compared with WTunder
isotonic conditions. This might be explained by a
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compensatory mechanism in which taurine release is in-
creased to compensate for the lacking anoctamin activity.
ANO6 is involved in cisplatin-induced apoptosis in ELA cells
AVD has been shown to be both necessary and sufficient
to initiate apoptosis in some cell types [7, 8, 22]. AVD is
very similar to RVD in many respects and several ion
channels, including ANO1 and VRAC, are involved in
both processes [1, 26, 29]. We therefore investigated if
ANO6 is involved in apoptosis. Our results show that
ANO6 plays an important role during cisplatin-induced
apoptosis in ELA cells (Fig. 5). This is similar to what
Martins et al. found in A549 cells [24], but in contradic-
tion to the findings of Shimizu et al., who showed that
KD of ANO6 does not affect staurosporine-induced AVD
in HeLa cells [33]. However, a previous study from our
group showed that the subset of ion channels activated
following apoptotic stimuli can vary considerably between
cell lines [35], and it is therefore quite possible that
ANO6 only contributes to apoptosis in some cell types.
With respect to RVD, we showed that influx of Ca2+ was
required for ANO6 to play a role in RVD. It is likely that
the same is true for AVD, i.e. only in cells where an early
influx of Ca2+ is seen there will be a contribution of
ANO6 to the AVD process.
Conclusions
Our whole-cell patch clamp data demonstrate that ANO6-
dependent Cl− currents, unlike VRAC currents, are not acti-
vated by osmotic cell volume increase in the absence of Ca2+
in the pipette. However, there may be not-yet-described com-
pensatory interactions between ANO6 and VRAC, as the
latter tend to increase its activity in the absence of ANO6.
Furthermore, we show that ANO6 plays a role in RVD pro-
vided there is Ca2+ in the bath, once again confirming the
central role of Ca2+ in opening of ANO6 channels. Finally, we
find that ANO6-KD reduces cisplatin-induced apoptosis in
ELA cells, suggesting that ANO6 contributes to AVD.
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Glossary
AVD Apoptotic volume decrease
CaCC Calcium-activated chloride channel
EATC Ehrlich ascites tumor cell
ELA Ehrlich–Lettre ascites
HEK Human embryonic kidney
KD Knock-down
RVD Regulatory volume decrease
VRAC Volume-regulated anion channel
VSOAC Volume-sensitive organic osmolyte and anion channel
WT Wild type
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